Advertisement
Screener

PharMerica CORP Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

PharMerica CORP Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

PharMerica CORP reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 46.34% for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2013-02-07

  • PharMerica CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2011 was 46.34%, a 1.76% increase from fiscal 2010.
  • PharMerica CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2010 was 45.54%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month
2012-06-3046.34%
10-Q · filed 2012-08-02
2011-12-3146.34%
10-K · filed 2013-02-07
2010-12-3145.54%
10-K · filed 2013-02-07